{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:59:42Z","timestamp":1780617582364,"version":"3.54.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,23]]},"DOI":"10.7759\/cureus.45805","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T07:50:21Z","timestamp":1695455421000},"source":"Crossref","is-referenced-by-count":1,"title":["Novel Approach in Cardiac Sarcoidosis: A Case Report Highlighting Abatacept as a Promising Treatment Option"],"prefix":"10.7759","author":[{"given":"Maamannan","family":"Venkataraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Pierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manush","family":"Sondhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravya","family":"Balmuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1712535","article-title":"Cardiac sarcoidosis","volume":"41","author":"Birnie DH","year":"2020","unstructured":"Birnie DH. Cardiac sarcoidosis. Semin Respir Crit Care Med. 2020, 41:626-40. 10.1055\/s-0040-1712535","journal-title":"Semin Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie DH","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, et al.. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014, 11:1305-23. 10.1016\/j.hrthm.2014.03.043","journal-title":"Heart Rhythm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1042\/bst024032s","article-title":"Purification of flavocytochrome b558: comparison between octylglucoside and a perfluoralkyl detergent","volume":"24","author":"Der Mardirossian C","year":"1996","unstructured":"Der Mardirossian C, Lederer F. Purification of flavocytochrome b558: comparison between octylglucoside and a perfluoralkyl detergent. Biochem Soc Trans. 1996, 24:32S. 10.1042\/bst024032s","journal-title":"Biochem Soc Trans"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai S","year":"2014","unstructured":"Nagai S, Yokomatsu T, Tanizawa K, et al.. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med. 2014, 53:427-33. 10.2169\/internalmedicine.53.0794","journal-title":"Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis","volume":"8","author":"Rosenthal DG","year":"2019","unstructured":"Rosenthal DG, Parwani P, Murray TO, et al.. Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis. J Am Heart Assoc. 2019, 8:e010952. 10.1161\/JAHA.118.010952","journal-title":"J Am Heart Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.10.005","article-title":"Anti-tumor necrosis factor agents in sarcoidosis: a systematic review of efficacy and safety","volume":"48","author":"Adler BL","year":"2019","unstructured":"Adler BL, Wang CJ, Bui TL, Schilperoort HM, Armstrong AW. Anti-tumor necrosis factor agents in sarcoidosis: a systematic review of efficacy and safety. Semin Arthritis Rheum. 2019, 48:1093-104. 10.1016\/j.semarthrit.2018.10.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100575","article-title":"Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial","volume":"19","author":"Frye BC","year":"2020","unstructured":"Frye BC, Rump IC, Uhlmann A, et al.. Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial. Contemp Clin Trials Commun. 2020, 19:100575. 10.1016\/j.conctc.2020.100575","journal-title":"Contemp Clin Trials Commun"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007393","article-title":"Comparative cardiovascular risk of abatacept and tumor necrosis factor inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus: a multidatabase cohort study","volume":"7","author":"Kang EH","year":"2018","unstructured":"Kang EH, Jin Y, Brill G, Lewey J, Patorno E, Desai RJ, Kim SC. Comparative cardiovascular risk of abatacept and tumor necrosis factor inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus: a multidatabase cohort study. J Am Heart Assoc. 2018, 7:10.1161\/JAHA.117.007393","journal-title":"J Am Heart Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170926","article-title":"Cardiovascular (CV) risk after initiation of abatacept versus TNF inhibitors in rheumatoid arthritis patients with and without baseline CV disease","volume":"45","author":"Jin Y","year":"2018","unstructured":"Jin Y, Kang EH, Brill G, Desai RJ, Kim SC. Cardiovascular (CV) risk after initiation of abatacept versus TNF inhibitors in rheumatoid arthritis patients with and without baseline CV disease. J Rheumatol. 2018, 45:1240-8. 10.3899\/jrheum.170926","journal-title":"J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/168417-novel-approach-in-cardiac-sarcoidosis-a-case-report-highlighting-abatacept-as-a-promising-treatment-option","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:00Z","timestamp":1707508440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/168417-novel-approach-in-cardiac-sarcoidosis-a-case-report-highlighting-abatacept-as-a-promising-treatment-option"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.45805","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,23]]}}}